Literature DB >> 11731461

Selective rescue of early haematopoietic progenitors in Scl(-/-) mice by expressing Scl under the control of a stem cell enhancer.

M J Sánchez1, E O Bockamp, J Miller, L Gambardella, A R Green.   

Abstract

The stem cell leukaemia gene (Scl) encodes a basic helix-loop-helix transcription factor with a pivotal role in both haematopoiesis and endothelial development. During mouse development, Scl is first expressed in extra-embryonic mesoderm, and is required for the generation of all haematopoietic lineages and normal yolk sac angiogenesis. Ectopic expression of Scl during zebrafish development specifies haemangioblast formation from early mesoderm. These results suggest that SCL is essential for establishing the transcriptional programme responsible for the formation of haematopoietic stem cells and have focused attention on the transcriptional regulation of Scl itself. Previous studies have identified a panel of Scl enhancers each of which directed expression to a subdomain of the normal Scl expression pattern. Among them, a 3' enhancer directed expression during development to vascular endothelium and haematopoietic progenitors but not to Ter119(+) erythroid cells. The expression in haematopoietic stem cells, however, remained undetermined. We demonstrate that this 3' enhancer directs lacZ expression in transgenic mice to most foetal and adult long-term repopulating haematopoietic stem cells, and therefore functions as a stem cell enhancer. Consistent with these results, expression in Scl(-/-) embryos of exogenous Scl driven by the stem cell enhancer rescued the formation of early haematopoietic progenitors and also resulted in normal yolk sac angiogenesis. By contrast, erythropoiesis remained markedly deficient in rescued embryos. This observation is consistent with the inactivity of the stem cell enhancer in erythroid cells and reveals an essential role for SCL during erythroid differentiation in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11731461     DOI: 10.1242/dev.128.23.4815

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  29 in total

1.  Analysis of multiple genomic sequence alignments: a web resource, online tools, and lessons learned from analysis of mammalian SCL loci.

Authors:  Michael A Chapman; Ian J Donaldson; James Gilbert; Darren Grafham; Jane Rogers; Anthony R Green; Berthold Göttgens
Journal:  Genome Res       Date:  2004-01-12       Impact factor: 9.043

2.  The scl +18/19 stem cell enhancer is not required for hematopoiesis: identification of a 5' bifunctional hematopoietic-endothelial enhancer bound by Fli-1 and Elf-1.

Authors:  Berthold Göttgens; Cyril Broccardo; Maria-Jose Sanchez; Sophie Deveaux; George Murphy; Joachim R Göthert; Ekaterini Kotsopoulou; Sarah Kinston; Liz Delaney; Sandie Piltz; Linda M Barton; Kathy Knezevic; Wendy N Erber; C Glenn Begley; Jonathan Frampton; Anthony R Green
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

3.  Functional but abnormal adult erythropoiesis in the absence of the stem cell leukemia gene.

Authors:  Mark A Hall; Nicholas J Slater; C Glenn Begley; Jessica M Salmon; Leonie J Van Stekelenburg; Matthew P McCormack; Stephen M Jane; David J Curtis
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

4.  Dynamic interaction between TAL1 oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and leukemogenesis.

Authors:  Y Li; C Deng; X Hu; B Patel; X Fu; Y Qiu; M Brand; K Zhao; S Huang
Journal:  Oncogene       Date:  2012-02-06       Impact factor: 9.867

5.  Gata2, Fli1, and Scl form a recursively wired gene-regulatory circuit during early hematopoietic development.

Authors:  John E Pimanda; Katrin Ottersbach; Kathy Knezevic; Sarah Kinston; Wan Y I Chan; Nicola K Wilson; Josette-Renée Landry; Andrew D Wood; Anja Kolb-Kokocinski; Anthony R Green; David Tannahill; Georges Lacaud; Valerie Kouskoff; Berthold Göttgens
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-25       Impact factor: 11.205

6.  The SCL +40 enhancer targets the midbrain together with primitive and definitive hematopoiesis and is regulated by SCL and GATA proteins.

Authors:  S Ogilvy; R Ferreira; S G Piltz; J M Bowen; B Göttgens; A R Green
Journal:  Mol Cell Biol       Date:  2007-08-20       Impact factor: 4.272

7.  Green fluorescent protein transgene driven by Kit regulatory sequences is expressed in hematopoietic stem cells.

Authors:  Francesco Cerisoli; Letizia Cassinelli; Giuseppe Lamorte; Stefania Citterio; Francesca Bertolotti; Maria Cristina Magli; Sergio Ottolenghi
Journal:  Haematologica       Date:  2009-01-30       Impact factor: 9.941

Review 8.  Of lineage and legacy: the development of mammalian hematopoietic stem cells.

Authors:  Elaine Dzierzak; Nancy A Speck
Journal:  Nat Immunol       Date:  2008-02       Impact factor: 25.606

9.  Transcriptional link between blood and bone: the stem cell leukemia gene and its +19 stem cell enhancer are active in bone cells.

Authors:  John E Pimanda; Lev Silberstein; Massimo Dominici; Benjamin Dekel; Mark Bowen; Scott Oldham; Asha Kallianpur; Stephen J Brandt; David Tannahill; Berthold Göttgens; Anthony R Green
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

10.  Genomic approaches uncover increasing complexities in the regulatory landscape at the human SCL (TAL1) locus.

Authors:  Pawandeep Dhami; Alexander W Bruce; Johanna H Jim; Shane C Dillon; Amanda Hall; Jonathan L Cooper; Nicolas Bonhoure; Kelly Chiang; Peter D Ellis; Cordelia Langford; Robert M Andrews; David Vetrie
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.